<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">76941</article-id><article-id pub-id-type="doi">10.7554/eLife.76941</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group></article-categories><title-group><article-title>Measuring the tolerance of the genetic code to altered codon size</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-266446"><name><surname>DeBenedictis</surname><given-names>Erika Alden</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7933-2651</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-39502"><name><surname>Söll</surname><given-names>Dieter</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3077-8986</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-100978"><name><surname>Esvelt</surname><given-names>Kevin M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8797-3945</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf3"/></contrib><aff id="aff1"><institution content-type="dept">Department of Biological Engineering</institution>, <institution>Massachusetts Institue of Technology</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Molecular Biophysics and Biochemistry</institution>, <institution>Yale University</institution>, <addr-line><named-content content-type="city">New Haven</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Media Arts and Sciences</institution>, <institution>Massachusetts Institute of Technology</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-22520"><name><surname>Nilsen</surname><given-names>Timothy W</given-names></name><role>Reviewing editor</role><aff><institution>Case Western Reserve University</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>erika.alden@mit.edu</email> (ED);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>16</day><month>03</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e76941</elocation-id><history><date date-type="received"><day>10</day><month>01</month><year>2022</year></date><date date-type="accepted"><day>15</day><month>03</month><year>2022</year></date></history><permissions><copyright-statement>© 2022, DeBenedictis et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>DeBenedictis et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-76941-v1.pdf"/><abstract><p>Translation using four-base codons occurs in both natural and synthetic systems. What constraints contributed to the universal adoption of a triplet-codon, rather than quadruplet-codon, genetic code? Here, we investigate the tolerance of the <italic>Escherichia coli </italic>genetic code to tRNA mutations that increase codon size. We found that tRNAs from all twenty canonical isoacceptor classes can be converted to functional quadruplet tRNAs (qtRNAs). Many of these selectively incorporate a single amino acid in response to a specified four-base codon, as confirmed with mass spectrometry. However, efficient quadruplet codon translation often requires multiple tRNA mutations. Moreover, while tRNAs were largely amenable to quadruplet conversion, only nine of the twenty aminoacyl tRNA synthetases tolerate quadruplet anticodons. These may constitute a functional and mutually orthogonal set, but one that sharply limits the chemical alphabet available to a nascent all-quadruplet code. Our results suggest that the triplet codon code was selected because it is simpler and sufficient, not because a quadruplet codon code is unachievable. These data provide a blueprint for synthetic biologists to deliberately engineer an all-quadruplet expanded genetic code.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>E. coli</italic></kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>R35GM122560</award-id><principal-award-recipient><name><surname>Söll</surname><given-names>Dieter</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>3R35GM122560-05W1</award-id><principal-award-recipient><name><surname>Söll</surname><given-names>Dieter</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>F31 AI145181-01</award-id><principal-award-recipient><name><surname>DeBenedictis</surname><given-names>Erika Alden</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>R00 DK102669-01</award-id><principal-award-recipient><name><surname>Esvelt</surname><given-names>Kevin M</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Erika Alden DeBenedictis, filed US Patent 16405380 on tRNA sequences engineered in this work...</p></fn><fn fn-type="conflict" id="conf3"><p>Kevin M Esvelt, filed US Patent 16405380 on tRNA sequences engineered in this work...</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All luminescence raw data are compiled in Figure 5A and provided as Source Data 1. Raw spectra have been deposited in the PRIDE database, dataset identifier PXD031925 and 10.6019/PXD031925.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>DeBenedictis EA</collab><collab>Esvelt K</collab></person-group><year iso-8601-date="2022">2022</year><source>Measurement of the amino acid incorporation of tRNAs engineered to decode four-base codons</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/pride/archive/projects/PXD031925">https://www.ebi.ac.uk/pride/archive/projects/PXD031925</ext-link><comment>PRIDE, PXD031925</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-76941-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>